Phase III Randomized Non-Inferiority Study of OSS Versus PEG plus Electrolyte Colonoscopy Preparation in Adolescents

被引:0
|
作者
Socha, Piotr [1 ,10 ]
Posovszky, Carsten [2 ,3 ]
Szychta, Monika [1 ]
Viscogliosi, Federica [5 ]
Martemucci, Luigi [4 ,5 ]
Grzybowska-Chlebowczyk, Urszula [5 ,6 ]
Perrot, Valerie [7 ]
Kornowski, Anne A. [8 ]
Benninga, Marc [9 ]
机构
[1] Childrens Mem Hlth Inst, Warsaw, Poland
[2] Univ Childrens Hosp, Zurich, Switzerland
[3] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany
[4] AORN Santobono Pausilibon, Naples, Italy
[5] John Paul II Upper Silesian Child Hlth Ctr, Katowice, Poland
[6] Med Univ Siles, Fac Med Sci, Dept Paediat 1, Katowice, Poland
[7] Ipsen Pharm, Boulogne Billancourt, France
[8] Ipsen Consumer HealthCare, Boulogne Billancourt, France
[9] Univ Amsterdam, Emma Childrens Hosp, Med Ctr, Amsterdam, Netherlands
[10] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Nutr Disorders & Pediat, Ul Aleja Dzieci Polskich 20, PL-04730 Warsaw, Poland
关键词
bowel cleansing; OSS; pediatrics; PEG; ORAL SULFATE-SOLUTION; BOWEL-PREPARATION; POLYETHYLENE-GLYCOL; REDUCED-VOLUME; EFFICACY; TRIAL; MULTICENTER; ENDOSCOPY; QUALITY; SAFETY;
D O I
10.1097/MPG.0000000000003745
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Many protocols and preparations are used for bowel cleansing before pediatric colonoscopy but few are based on scientific evidence. We evaluated efficacy, safety, tolerability, and patient preference of oral sulfate solution (OSS) at 75% of the adult dose versus polyethylene glycol (PEG)-electrolyte solution in adolescents presenting for diagnostic colonoscopy.Methods: Phase III, randomized, evaluator-blinded, non-inferiority study of OSS and PEG in adolescents aged 12-17 years. OSS and PEG were administered in 2 doses on the day before colonoscopy. Primary endpoint included proportion of patients with successful overall preparation (4-point scale). Secondary endpoints included overall and segmental bowel cleansing (Boston Bowel Preparation Scale; BBPS), completed colonoscopies, duration of examination, time to cecal intubation, proportion of nasogastric tubes (NGTs), adverse events (AEs) and acceptability.Results: Successful cleansing was achieved in 71.4% and 79.0% of patients receiving OSS and PEG, respectively [adjusted difference -7.61 (95% confidence interval, CI, -18.45 to 3.24); P = 0.0907]. Segmental BBPS score for the left and transverse colon were similar between treatment groups, but better for the right colon with PEG than OSS [2.2 (95% CI, 2.0-2.4) and 1.9 (95% CI, 1.7-2.1), respectively; P = 0.0015]. Significantly fewer OSS patients needed NGT placement to ingest the whole solution [9/125 (7.2%)] than PEG patients [36/116 (31.0%); P < 0.0001]. Treatment acceptability was significantly higher with OSS than PEG (P < 0.0001). Duration of examination, completed colonoscopies, and time to cecal intubation were similar between preparations. Gastrointestinal AEs including nausea, vomiting, abdominal pain, and distension were similar in both groups but more patients receiving PEG had AEs assessed as incapacitating.Conclusions: Non-inferiority of OSS to PEG was not demonstrated, but OSS was associated with a lower requirement for NGT, better acceptability, and less frequent severe AEs than with PEG.
引用
收藏
页码:652 / 659
页数:8
相关论文
共 50 条
  • [31] A non-inferiority randomized controlled study of Perampanel versus Oxcarbazepine monotherapy for post-stroke epilepsy
    Yan, Cuihua
    Liu, Jing
    Jiang, Jing
    Sun, Yanping
    Chen, Juan
    Wei, Kunkun
    Liu, Xiaoyun
    Xiang, Qi
    Liu, Anru
    Han, Yuxiang
    Yang, Liling
    Han, Tao
    Liu, Xuewu
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2025, 125 : 172 - 178
  • [32] Efficacy and safety of tegoprazan for duodenal ulcers in Chinese patients: a multicenter, randomized, double-blind, non-inferiority, phase III study
    Zong, Ye
    Lan, Cheng
    Li, Xing
    Chen, Weixing
    Chen, Honghui
    Liao, Aijun
    Liu, Side
    Hu, Chanyan
    Wu, Yongdong
    Zhang, Shutian
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (11) : 1855 - 1862
  • [33] A Non-Inferiority Study on Endometrial Preparation Prior to FET-Letrozole Versus Hormone Replacement Therapy
    Rao, Asha R.
    Aiswarya, R.
    Padmashri, G.
    Rao, Damodar
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2024, 74 (05): : 405 - 410
  • [34] Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Nahi, Hareth
    Legiec, Wojciech
    Grosicki, Sebastian
    Vorobyev, Vladimir
    Spicka, Ivan
    Hungria, Vania
    Korenkova, Sibirina
    Bahlis, Nizar J.
    Flogegard, Max
    Blade, Joan
    Moreau, Philippe
    Kaiser, Martin
    Iida, Shinsuke
    Laubach, Jacob
    Magen, Hila
    Cavo, Michele
    Hulin, Cyrille
    White, Darrell
    De Stefano, Valerio
    Lantz, Kristen
    O'Rourke, Lisa
    Heuck, Christoph
    Delioukina, Maria
    Qin, Xiang
    Nnane, Ivo
    Qi, Ming
    Mateos, Maria-Victoria
    HAEMATOLOGICA, 2022, 107 (10) : 2408 - 2417
  • [35] A Prospective Randomized Controlled Trial of AJG522 versus Standard PEG plus E as Bowel Preparation for Colonoscopy
    Sagawa, Toshihiko
    Sato, Ken
    Tomizawa, Taku
    Mizuide, Masafumi
    Yasuoka, Hidetoshi
    Shimoyama, Yasuyuki
    Kuribayashi, Shiko
    Kakizaki, Satoru
    Kawamura, Osamu
    Kusano, Motoyasu
    Yamada, Masanobu
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [36] Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)
    Koeberle, D.
    Betticher, D. C.
    von Moos, R.
    Dietrich, D.
    Brauchli, P.
    Baertschi, D.
    Matter, K.
    Winterhalder, R.
    Borner, M.
    Anchisi, S.
    Moosmann, P.
    Kollar, A.
    Saletti, P.
    Roth, A.
    Frueh, M.
    Kueng, M.
    Popescu, R. A.
    Schacher, S.
    Hess, V.
    Herrmann, R.
    ANNALS OF ONCOLOGY, 2015, 26 (04) : 709 - 714
  • [37] Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial
    Kim, Eun Hye
    Lee, Yong Chan
    Chang, Young Woon
    Park, Jong-Jae
    Chun, Hoon Jai
    Jung, Hwoon-Yong
    Kim, Hyun-Soo
    Jeong, Hyun Yong
    Seol, Sang-Young
    Han, Sok Won
    Choi, Myung-Gyu
    Park, Soo-Heon
    Lee, Ok-Jae
    Jung, Jin Tae
    Lee, Dong Ho
    Jung, Hyun Chae
    Lee, Soo Teik
    Kim, Jae Gyu
    Youn, Sei Jin
    Kim, Hak Yang
    Lee, Sang Woo
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (06) : 1724 - 1732
  • [38] Preoperative mechanical bowel preparation using conventional versus hyperosmolar polyethylene glycol-electrolyte lavage solution before laparoscopic resection for colorectal cancer (TLUMP test): a phase III, multicenter randomized controlled non-inferiority trial
    Tadashi Yoshida
    Shigenori Homma
    Nobuki Ichikawa
    Yosuke Ohno
    Yoichi Miyaoka
    Hiroki Matsui
    Ken Imaizumi
    Hiroyuki Ishizu
    Tohru Funakoshi
    Masahiko Koike
    Hirofumi Kon
    Yo Kamiizumi
    Yasuhiro Tani
    Yoichi Minagawa Ito
    Kazufumi Okada
    Akinobu Taketomi
    Journal of Gastroenterology, 2023, 58 : 883 - 893
  • [39] Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
    von Au, Alexandra
    Milloth, Eva
    Diel, Ingo
    Stefanovic, Stefan
    Hennigs, Andre
    Wallwiener, Markus
    Heil, Joerg
    Golatta, Michael
    Rom, Joachim
    Sohn, Christof
    Schneeweiss, Andreas
    Schuetz, Florian
    Domschke, Christoph
    ONCOTARGETS AND THERAPY, 2016, 9 : 4173 - 4180
  • [40] Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial
    Eun Hye Kim
    Yong Chan Lee
    Young Woon Chang
    Jong-Jae Park
    Hoon Jai Chun
    Hwoon-Yong Jung
    Hyun-Soo Kim
    Hyun Yong Jeong
    Sang-Young Seol
    Sok Won Han
    Myung-Gyu Choi
    Soo-Heon Park
    Ok-Jae Lee
    Jin Tae Jung
    Dong Ho Lee
    Hyun Chae Jung
    Soo Teik Lee
    Jae Gyu Kim
    Sei Jin Youn
    Hak Yang Kim
    Sang Woo Lee
    Digestive Diseases and Sciences, 2015, 60 : 1724 - 1732